DOCSLIB.ORG

Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats Kehong Zhang, M.D., Ph.D., Frank I

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats Kehong Zhang, M.D., Ph.D., Frank I Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats Kehong Zhang, M.D., Ph.D., Frank I. Tarazi, Ph.D., and Ross J. Baldessarini, M.D. The role of dopamine D4 receptors in behavioral hyperactivity D4-selective antagonist CP-293,019 dose-dependently was investigated by assessing D4 receptor expression in brain reversed lesion-induced hyperactivity, and D4-agonist CP- regions and behavioral effects of D4 receptor-selective ligands 226,269 increased it. These results indicate a physiological in juvenile rats with neonatal 6-hydroxydopamine lesions, a role of dopamine D4 receptors in motor behavior, and may laboratory model for attention deficit-hyperactivity disorder suggest much-needed innovative treatments for ADHD. (ADHD). Autoradiographic analysis indicated that motor [Neuropsychopharmacology 25:624–632, 2001] hyperactivity in lesioned rats was closely correlated with © 2001 American College of Neuropsychopharmacology. increases in D4 but not D2 receptor levels in caudate-putamen. Published by Elsevier Science Inc. KEY WORDS: Attention deficit-hyperactivity disorder; Human D4 receptors occur in multiple forms with 2– Autoradiography; Dopamine; D4; 6-hydroxydopamine; 11 copies of a 16-amino acid (48 base-pair) sequence in Motor activity the putative third intracellular loop of the peptide (Van Dopamine (DA) modulates physiological processes Tol et al. 1992; Lichter et al. 1993; Asghari et al. 1994). through activation of five G-protein coupled receptors Several recent genetic studies indicate that the 7-repeat D4 receptor allele (D4.7), a relatively uncommon variant, of the D1-like (D1 and D5) and D2-like (D2, D3, and D4) re- ceptor families (Neve and Neve 1997). Since the cloning is more prevalent in patients with attention deficit- hyperactivity disorder (ADHD) (La Hoste et al. 1996; of their cDNA (Van Tol et al. 1991), D4 receptors have re- ceived much attention, in part because some atypical an- Bailey et al. 1997; Rowe et al. 1998; Faraone et al. 1999). Haplotype relative-risk analysis to assess allele trans- tipsychotics, notably clozapine, bind to D4 receptors with somewhat higher affinity than to the more preva- mission also suggests that the D4.7 receptor may be as- sociated with ADHD (Swanson et al. 1998). The same lent D2 receptors (Van Tol et al. 1991; Seeman et al. 1997; Tarazi et al. 1997; Tarazi and Baldessarini 1999). D4.7 phenotype is also linked to personality traits re- lated to ADHD, notably, novelty-seeking and impulsiv- ity (Benjamin et al. 1996; Ebstein et al. 1996; Comings et From the Mailman Research Center, McLean Division of Massa- al. 1999). Biochemical analysis of these D receptor vari- chusetts General Hospital, 115 Mill Street, Belmont, MA 02478, 4 USA; and Consolidated Department of Psychiatry and Neuro- ants indicates that D4.7 receptors are less efficient in science Program, Harvard Medical School, Boston, MA 02115 USA. transducing extracellular DA signals to intracellular Address correspondence to: Kehong Zhang, M.D., Ph.D., Mail- adenylyl cyclase than other forms with fewer repeat se- man Research Center, McLean Hospital, 115 Mill Street, Belmont, MA 02478, Tel.: 617-855-3222; Fax: 617-855-3479, E-mail: kz@mclean. quences (Asghari et al. 1995). harvard.edu ADHD is a neuropsychiatric syndrome frequently Received November 14, 2000; revised March 28, 2001; accepted found in school-aged children, especially boys, that is April 9, 2001. Online publication: 4/10/01 at www.acnp.org/citations/Npp characterized by excesses of hyperactive, inattentive, 041001102. and impulsive behavior (Barkley 1990). Salient features NEUROPSYCHOPHARMACOLOGY 2001–VOL. 25, NO. 5 © 2001 American College of Neuropsychopharmacology Published by Elsevier Science Inc. 0893-133X/01/$–see front matter 655 Avenue of the Americas, New York, NY 10010 PII S0893-133X(01)00262-7 NEUROPSYCHOPHARMACOLOGY 2001–VOL. 25, NO. 5 Dopamine D4 Receptors and Hyperactivity 625 of ADHD are commonly modeled in juvenile rats fol- hydrochloride was provided by Celgene (Warren, NJ). lowing neonatal lesioning with 6-hydroxydopamine (6- CP-226,269 and CP-293,019 were generously donated OHDA) which destroys DA projections to forebrain by Pfizer (Groton, CT). All other drugs and chemicals (Shaywitz et al. 1976). Such rats exhibit several charac- were purchased from Fisher Scientific (Dallas, TX) or teristics resembling core symptoms of ADHD, most no- Sigma Chemicals (St. Louis, MO). tably, motor hyperactivity that occurs selectively dur- ing the periadolescent period, gradually declines as Neonatal Lesioning lesioned rats mature, and seems to represent deficient adaptation to environmental stimuli (Erinoff et al. Sprague-Dawley rats (Charles River Labs., Wilming- 1979). The motor hyperactivity in this model can be ton, MA) were maintained under a 12-h artificial day- dose-dependently antagonized by psychostimulants light/dark schedule (on, 7 A.M.-7 P.M.), with free access that are commonly used to alleviate symptoms of to tap-water and standard rat chow. On postnatal day ADHD (Heffner and Seiden 1982; Luthman et al. 1989). (PD) 1, male pups were assigned to lactacting dam (10/ Hyperactivity and attentional deficits that occur in each). On PD 5, pups received a subcutaneous injection ADHD are also modeled with genetic knockout mice of desipramine hydrochloride (25 mg/kg). 45 Minutes that lack functional DA transporters (DAT) (Giros et al. later, pups randomly received an intracisternal injec- 1996; Gainedtinov et al. 1999). However, the patho- tion of vehicle (0.9% NaCl containing 0.1% ascorbic physiology of these models may be dissimilar, and may acid), or 6-OHDA hydrobromide (100 ␮g free base) un- or may not reflect mechanisms underlying clinical der hypothermal anesthesia (Shaywitz et al. 1976). Pups ADHD. Notably, the 6-OHDA lesioning model in- were returned to nursing dams immediately after the volves neonatal removal of DA with overgrowth of se- intracranial injections. A total of 210 rat pups were in- rotonin projections to forebrain (Kostrzewa et al. 1998), cluded in the study. All procedures were approved by whereas the DAT knockout mouse involves a loss of the the McLean Hospital Institutional Animal Care and Use major mechanism for inactivating DA (Gainedtinov et Committee, in compliance with applicable federal and al. 1999)—a mechanism that may be overexpressed in local guidelines for experimental use of animals. The clinical ADHD (Dougherty et al. 1999; Dresel et al. extent of lesioning was verified by quantifying DAT 2000). binding with [3H]␤-CIT (Kula et al. 1999) at the comple- Association of D4 receptor polymorphism with tion of behavioral experiments. ADHD led us to study the expression of D4 receptors in juvenile rats following neonatal 6-OHDA lesions using Behavioral Experiments quantitative autoradiography. DA D1-like and D2-like receptor binding was examined for comparison. Effects Motor activity was monitored individually for 90 of highly D4-selective agents on hyperactivity were min in the periadolescent period between PD 21 and 30, studied and compared to representative stimulants using an infrared photobeam activity monitoring sys- used to treat ADHD. tem (San Diego Instruments, San Diego, CA) connected with a microcomputer. Behavioral testings were con- ducted in a novel environment (17ϫ8ϫ8 inch transpar- MATERIALS AND METHODS ent plastic cages with 4ϫ8 horizontal infrared beams), usually between 10:00 and 16:00 h in the absence of Radioligands and Chemicals food and water, except for experiments involving noc- [3H]Nemonapride (R[ϩ]-7-chloro-8-hydroxy-3-methyl- turnal testing (at 22:00–04:00 h). Locomotor activity was 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine; 85.5 Ci/ defined as breaking of consecutive photobeams, and ac- mmol) and [3H]SCH-23390 (R[ϩ]-2,3,4,5-tetrahydro- cumulated every 5 min. 3-methyl-5-phenyl-1H-3-benzazepin-7-ol; 81.4 Ci/ Test agents were dissolved in 0.9% saline or 35% mmol) were obtained from New England Nuclear 2-hydroxypropyl-␤-cyclodextrin, and given intraperito- (NEN; Boston, MA). [3H]␤-CIT ([–]-2-␤-carbometh- neally (i.p.) immediately prior to testing. Each subject oxy-3-␤-[4-iodophenyl]-tropane; 64.7Ci/mmol) was ob- was evaluated in two behavioral testing sessions (one tained from Tocris Cookson (Bristol, UK). Tritium-sen- with vehicle, the other with a test drug), separated by at sitive Hyperfilm and autoradiography standards were least three days, and in randomized order. Some rats from Amersham (Arlington Heights, IL). D-19 devel- given CP-293,019 were pretreated with methysergide oper and fixative were from Eastman-Kodak (Roches- (2 mg/kg, i.p.) 30 min before behavioral testing. ter, NY). (ϩ)-Amphetamine sulfate, 1,3-ditolylguani- dine (DTG), cis-flupenthixol dihydrochloride, 6-OHDA Receptor Autoradiography hydrobromide, ketanserin tartrate, S(–)-pindolol, and S(–)-sulpiride were from Sigma–Research Biochemicals Rats were sacrificed 48 h after the last behavioral test- International (RBI; Natick, MA). (ϩ)-Methylphenidate ing session (on PD 32) by rapid decapitation, and brains 626 K. Zhang et al. NEUROPSYCHOPHARMACOLOGY 2001–VOL. 25, NO. 5 were quickly removed and frozen. Coronal brain sec- nocturnal testing (Figure 1, Panels A and B). Notably, tions (10 ␮m) were prepared in a cryostat at –17ЊC, thaw- motor activity of lesioned rats did not differ signifi- mounted on gelatin-coated microscopic slides and stored cantly from controls for the first 5–10 min of testing ses- at –80ЊC until quantitative autoradiographic assays. sion, but failed to decline throughout the 90 min ses- Densities of D2-like and D4 receptors were deter- sion, long after arousal in control rats had greatly mined autoradiographically as previously detailed and diminished. Hyperactivity in lesioned rats was reduced characterized pharmacologically (Tarazi et al. 1997, by both (ϩ)-amphetamine and (ϩ)-methylphenidate 1998a,b). Briefly, tissue sections were preincubated for (Figure 1, Panel C). In contrast to their motor-inhibiting 60 min at room temp in 50 mM Tris-HCl buffer contain- effects in lesioned rats, both psychostimulants greatly ing (mM): NaCl (120), KCl (5), CaCl2 (2), and MgCl2 (1).
Load more

Recommended publications
  • A Role for Sigma Receptors in Stimulant Self Administration and Addiction
    Pharmaceuticals 2011, 4, 880-914; doi:10.3390/ph4060880 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review A Role for Sigma Receptors in Stimulant Self Administration and Addiction Jonathan L. Katz *, Tsung-Ping Su, Takato Hiranita, Teruo Hayashi, Gianluigi Tanda, Theresa Kopajtic and Shang-Yi Tsai Psychobiology and Cellular Pathobiology Sections, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, 21224, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]. Received: 16 May 2011; in revised form: 11 June 2011 / Accepted: 13 June 2011 / Published: 17 June 2011 Abstract: Sigma1 receptors (σ1Rs) represent a structurally unique class of intracellular proteins that function as chaperones. σ1Rs translocate from the mitochondria-associated membrane to the cell nucleus or cell membrane, and through protein-protein interactions influence several targets, including ion channels, G-protein-coupled receptors, lipids, and other signaling proteins. Several studies have demonstrated that σR antagonists block stimulant-induced behavioral effects, including ambulatory activity, sensitization, and acute toxicities. Curiously, the effects of stimulants have been blocked by σR antagonists tested under place-conditioning but not self-administration procedures, indicating fundamental differences in the mechanisms underlying these two effects. The self administration of σR agonists has been found in subjects previously trained to self administer cocaine. The reinforcing effects of the σR agonists were blocked by σR antagonists. Additionally, σR agonists were found to increase dopamine concentrations in the nucleus accumbens shell, a brain region considered important for the reinforcing effects of abused drugs.
    [Show full text]
  • Cerebellar Toxicity of Phencyclidine
    The Journal of Neuroscience, March 1995, 75(3): 2097-2108 Cerebellar Toxicity of Phencyclidine Riitta N&kki, Jari Koistinaho, Frank Ft. Sharp, and Stephen M. Sagar Department of Neurology, University of California, and Veterans Affairs Medical Center, San Francisco, California 94121 Phencyclidine (PCP), clizocilpine maleate (MK801), and oth- Phencyclidine (PCP), dizocilpine maleate (MK801), and other er NMDA antagonists are toxic to neurons in the posterior NMDA receptor antagonistshave attracted increasing attention cingulate and retrosplenial cortex. To determine if addition- becauseof their therapeutic potential. These drugs have neuro- al neurons are damaged, the distribution of microglial ac- protective properties in animal studies of focal brain ischemia, tivation and 70 kDa heat shock protein (HSP70) induction where excitotoxicity is proposedto be an important mechanism was studied following the administration of PCP and of neuronal cell death (Dalkara et al., 1990; Martinez-Arizala et MK801 to rats. PCP (10-50 mg/kg) induced microglial ac- al., 1990). Moreover, NMDA antagonists decrease neuronal tivation and neuronal HSP70 mRNA and protein expression damage and dysfunction in other pathological conditions, in- in the posterior cingulate and retrosplenial cortex. In ad- cluding hypoglycemia (Nellgard and Wieloch, 1992) and pro- dition, coronal sections of the cerebellar vermis of PCP (50 longed seizures(Church and Lodge, 1990; Faingold et al., 1993). mg/kg) treated rats contained vertical stripes of activated However, NMDA antagonists are toxic to certain neuronal microglial in the molecular layer. In the sagittal plane, the populations in the brain. Olney et al. (1989) demonstratedthat microglial activation occurred in irregularly shaped patch- the noncompetitive NMDA antagonists,PCP, MK801, and ke- es, suggesting damage to Purkinje cells.
    [Show full text]
  • The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor
    Journal of Cancer 2019, Vol. 10 1622 Ivyspring International Publisher Journal of Cancer 2019; 10(7): 1622-1632. doi: 10.7150/jca.27780 Review The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor Xu Wang1,2, Zhi-Bin Wang1,2, Chao Luo1,2,4, Xiao-Yuan Mao1,2, Xi Li1,2, Ji-Ye Yin1,2, Wei Zhang1,2,3, Hong-Hao Zhou1,2,3, Zhao-Qian Liu1,2,3 1. Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P. R. China; 2. Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, P. R. China; 3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, P. R. China; 4. School of Life Sciences, Central South University, Changsha, Hunan 410078. Corresponding author: Professor Zhao-Qian Liu: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P. R. China; Institute of Clinical Pharmacology, Central South University; Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, P. R. China. Tel: +86 731 89753845, Fax: +86 731 82354476, E-mail: [email protected]. © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2018.06.10; Accepted: 2019.02.07; Published: 2019.03.03 Abstract Dopamine receptors are belong to the family of G protein-coupled receptor. There are five types of dopamine receptor (DR), including DRD1, DRD2, DRD3, DRD4, and DRD5, which are divided into two major groups: the D1-like receptors (DRD1 and DRD5), and the D2-like receptors (DRD2, DRD3, and DRD4).
    [Show full text]
  • Gαq-ASSOCIATED SIGNALING PROMOTES NEUROADAPTATION to ETHANOL and WITHDRAWAL-ASSOCIATED HIPPOCAMPAL DAMAGE
    University of Kentucky UKnowledge Theses and Dissertations--Psychology Psychology 2015 Gαq-ASSOCIATED SIGNALING PROMOTES NEUROADAPTATION TO ETHANOL AND WITHDRAWAL-ASSOCIATED HIPPOCAMPAL DAMAGE Anna R. Reynolds Univerity of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Reynolds, Anna R., "Gαq-ASSOCIATED SIGNALING PROMOTES NEUROADAPTATION TO ETHANOL AND WITHDRAWAL-ASSOCIATED HIPPOCAMPAL DAMAGE" (2015). Theses and Dissertations--Psychology. 74. https://uknowledge.uky.edu/psychology_etds/74 This Doctoral Dissertation is brought to you for free and open access by the Psychology at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Psychology by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known. I agree that the document mentioned above may be made available immediately for worldwide access unless an embargo applies.
    [Show full text]
  • 5-HT7 Receptor Neuroprotection Against Excitotoxicity in the Hippocampus,” AFPC, Quebec City, June 2012
    5-HT7 Receptor Neuroprotection against Excitotoxicity in the Hippocampus by Seyedeh Maryam Vasefi A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in Pharmacy Waterloo, Ontario, Canada, 2014 ©Seyedeh Maryam Vasefi 2014 i AUTHOR'S DECLARATION I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii Abstract Introduction and Objectives: The PDGFβ receptor and its ligand, PDGF-BB, are expressed throughout the central nervous system (CNS), including the hippocampas. Several reports confirm that PDGFβ receptors are neuroprotective against N-methyl-D-asparate (NMDA)-induced cell death in hippocampal neurons. NMDA receptor dysfunction is important for the expression of many symptoms of mental health disorders such as schizophrenia. The serotonin (5-HT) type 7 receptor was the most recent of the 5-HT receptor family to be identified and cloned. 5-HT receptors interact with several signaling systems in the CNS including receptors activated by the excitatory neurotransmitter glutamate such as the NMDA receptor. Although there is extensive interest in targeting the 5-HT7 receptor with novel therapeutic compounds, the function and signaling properties of 5-HT7 receptors in neurons remains poorly characterized. Methods: The SH-SY5Y neuroblastoma cell line, primary hippocampal cultures, and hippocampal slices were treated with 5-HT7 receptor agonists and antagonists. Western blotting was used to measure PDGFß receptor expression and phosphorylation as well as NMDA receptor subunit expression and phosphorylation levels.
    [Show full text]
  • Identification of Key Pathways and Genes in Dementia Via Integrated Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.18.440371; this version posted July 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of Key Pathways and Genes in Dementia via Integrated Bioinformatics Analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.04.18.440371; this version posted July 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract To provide a better understanding of dementia at the molecular level, this study aimed to identify the genes and key pathways associated with dementia by using integrated bioinformatics analysis. Based on the expression profiling by high throughput sequencing dataset GSE153960 derived from the Gene Expression Omnibus (GEO), the differentially expressed genes (DEGs) between patients with dementia and healthy controls were identified. With DEGs, we performed a series of functional enrichment analyses. Then, a protein–protein interaction (PPI) network, modules, miRNA-hub gene regulatory network and TF-hub gene regulatory network was constructed, analyzed and visualized, with which the hub genes miRNAs and TFs nodes were screened out. Finally, validation of hub genes was performed by using receiver operating characteristic curve (ROC) analysis.
    [Show full text]
  • The Genetics of Bipolar Disorder
    Molecular Psychiatry (2008) 13, 742–771 & 2008 Nature Publishing Group All rights reserved 1359-4184/08 $30.00 www.nature.com/mp FEATURE REVIEW The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions A Serretti and L Mandelli Institute of Psychiatry, University of Bologna, Bologna, Italy Bipolar disorder (BP) is a complex disorder caused by a number of liability genes interacting with the environment. In recent years, a large number of linkage and association studies have been conducted producing an extremely large number of findings often not replicated or partially replicated. Further, results from linkage and association studies are not always easily comparable. Unfortunately, at present a comprehensive coverage of available evidence is still lacking. In the present paper, we summarized results obtained from both linkage and association studies in BP. Further, we indicated new potential interesting genes, located in genome ‘hot regions’ for BP and being expressed in the brain. We reviewed published studies on the subject till December 2007. We precisely localized regions where positive linkage has been found, by the NCBI Map viewer (http://www.ncbi.nlm.nih.gov/mapview/); further, we identified genes located in interesting areas and expressed in the brain, by the Entrez gene, Unigene databases (http://www.ncbi.nlm.nih.gov/entrez/) and Human Protein Reference Database (http://www.hprd.org); these genes could be of interest in future investigations. The review of association studies gave interesting results, as a number of genes seem to be definitively involved in BP, such as SLC6A4, TPH2, DRD4, SLC6A3, DAOA, DTNBP1, NRG1, DISC1 and BDNF.
    [Show full text]
  • SZDB: a Database for Schizophrenia Genetic Research
    Schizophrenia Bulletin vol. 43 no. 2 pp. 459–471, 2017 doi:10.1093/schbul/sbw102 Advance Access publication July 22, 2016 SZDB: A Database for Schizophrenia Genetic Research Yong Wu1,2, Yong-Gang Yao1–4, and Xiong-Jian Luo*,1,2,4 1Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Kunming, China; 2Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, China; 3CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China 4YGY and XJL are co-corresponding authors who jointly directed this work. *To whom correspondence should be addressed; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China; tel: +86-871-68125413, fax: +86-871-68125413, e-mail: [email protected] Schizophrenia (SZ) is a debilitating brain disorder with a Introduction complex genetic architecture. Genetic studies, especially Schizophrenia (SZ) is a severe mental disorder charac- recent genome-wide association studies (GWAS), have terized by abnormal perceptions, incoherent or illogi- identified multiple variants (loci) conferring risk to SZ. cal thoughts, and disorganized speech and behavior. It However, how to efficiently extract meaningful biological affects approximately 0.5%–1% of the world populations1 information from bulk genetic findings of SZ remains a and is one of the leading causes of disability worldwide.2–4 major challenge. There is a pressing
    [Show full text]
  • Sigma,-Binding Site MARKUS HANNER*, FABIAN F
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 8072-8077, July 1996 Pharmacology Purification, molecular cloning, and expression of the mammalian sigma,-binding site MARKUS HANNER*, FABIAN F. MOEBIUS*t, ASTRID FLANDORFER*, HANS-GUNTHER KNAUS*, JORG STRIESSNIG*, ELLIS KEMPNERt, AND HARTMUT GLOSSMANN* *Institut fur Biochemische Pharmakologie, Universitat Innsbruck, Peter Mayr Strasse 1, A-6020 Innsbruck, Austria; and tNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892 Communicated by James Black, King's College School of Medicine and Dentistry, London, United Kingdom, April 18, 1996 (received for review March 1, 1996) ABSTRACT Sigma-ligands comprise several chemically The verapamil-like calcium-antagonists azidopamil (a pho- unrelated drugs such as haloperidol, pentazocine, and ditolyl- toligand) and emopamil (an antiischemic drug) are also high- guanidine, which bind to a family of low molecular mass affinity sigma-ligands that were previously employed as specific proteins in the endoplasmic reticulum. These so-called sigma- probes to purify and clone a novel drug-binding membrane receptors are believed to mediate various pharmacological protein from liver. This was distinct from the sigma1-binding site, effects of sigma-ligands by as yet unknown mechanisms. Based although it showed substantial pharmacological and biochemical on their opposite enantioselectivity for benzomorphans and similarities with sigma-receptors (26-29). Until now, sigma- different molecular masses, two subtypes are differentiated. ligand studies suffered from the lack of structural information. To We purified the sigma,-binding site as a single 30-kDa protein clarify its primary structure, we purified the protein carrying the from guinea pig liver employing the benzomorphan sigma,-binding site and cloned the corresponding cDNA using (+) [3H]pentazocine and the arylazide (-) [3H]azidopamil as reverse transcriptase-PCR and degenerate oligonucleotides.
    [Show full text]
  • Crystal Structure of Dopamine Receptor D4 Bound to the Subtype Selective Ligand, L745870 Ye Zhou1,2, Can Cao1, Lingli He1, Xianping Wang1, Xuejun Cai Zhang1,2*
    RESEARCH ARTICLE Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870 Ye Zhou1,2, Can Cao1, Lingli He1, Xianping Wang1, Xuejun Cai Zhang1,2* 1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China; 2University of Chinese Academy of Sciences, Beijing, China Abstract Multiple subtypes of dopamine receptors within the GPCR superfamily regulate neurological processes through various downstream signaling pathways. A crucial question about the dopamine receptor family is what structural features determine the subtype-selectivity of potential drugs. Here, we report the 3.5-angstrom crystal structure of mouse dopamine receptor D4 (DRD4) complexed with a subtype-selective antagonist, L745870. Our structure reveals a secondary binding pocket extended from the orthosteric ligand-binding pocket to a DRD4-specific crevice located between transmembrane helices 2 and 3. Additional mutagenesis studies suggest that the antagonist L745870 prevents DRD4 activation by blocking the relative movement between transmembrane helices 2 and 3. These results expand our knowledge of the molecular basis for the physiological functions of DRD4 and assist new drug design. Introduction Dopamine and its receptors play fundamental roles in controlling neurological processes including motor control, cognition, learning, and emotions (Beaulieu and Gainetdinov, 2011). Dopaminergic *For correspondence: dysfunction is associated with the
    [Show full text]
  • 4-Aroylpiperidines and 4-(Α-Hydroxyphenyl)Piperidines As Selective Sigma-1 Receptor Ligands: Synthesis, Preliminary Pharmacolog
    Ikome et al. Chemistry Central Journal (2016) 10:53 DOI 10.1186/s13065-016-0200-1 RESEARCH ARTICLE Open Access 4‑aroylpiperidines and 4‑(α‑hydroxyphenyl)piperidines as selective sigma‑1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies Hermia N. Ikome1, Fidele Ntie‑Kang1,2* , Moses N. Ngemenya3, Zhude Tu4, Robert H. Mach4 and Simon M. N. Efange1* Abstract Background: Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their poten‑ tial as alternative targets for antipsychotic agents. Sigma receptors display diverse biological activities and represent potential fruitful targets for therapeutic development in combating many human diseases. Therefore, they present an interesting avenue for further exploration. It was our goal to evaluate the potential of ring opened spipethiane (1) analogues as functional ligands (agonists) for σ receptors by chemical modification. Results: Chemical modification of the core structure of the lead compound, (1), by replacement of the sulphur atom with a carbonyl group, hydroxyl group and 3-bromobenzylamine with the simultaneous presence of 4-fluorobenzoyl replacing the spirofusion afforded novel potent sigma-1 receptor ligands 7a–f, 8a–f and 9d–e. The sigma-1 receptor affinities of 7e, 8a and 8f were slightly lower than that of 1 and their selectivities for this receptor two to threefold greater than that of 1. Conclusions: It was found that these compounds have higher selectivities for sigma-1 receptors compared to 1. Quantitatitive structure–activity relationship studies revealed that sigma-1 binding is driven by hydrophobic interactions.
    [Show full text]
  • Binding Characteristics of Σ 2 Receptor Ligands
    Revista Brasileira de Ciências Farmacêuticas Brazilian Journal of Pharmaceutical Sciences vol. 41, n. 1, jan./mar., 2005 σ Binding characteristics of 2 receptor ligands Richard A. Glennon Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298-0540, USA Sigma ( ) receptors, once considered a type of opioid receptor, are Uniterms σ σ • 2 receptor now recognized as representing a unique receptive entity and at σ • 2 ligand structural features least two different types of σ receptors have been identified: σ σ 1 • 2 pharmacophore model and σ2 receptors. Evidence suggests that these receptors might be targeted and exploited for the development of agents potentially useful for the treatment of several central disorders. This review primarily describes some of our efforts to understand those structural features that contribute to σ2 receptor binding, and some recent work by other investigators is also included. Despite an inability to formulate a unified pharmacophore model for σ2 Correspondence: Richard A. Glennon, PhD binding due to the diversity of structure-types that bind at the Box 980540 receptor, and to the conformational flexibility of these ligands, School of Pharmacy significant progress has been made toward the development of some Virginia Commonwealth University Richmond, VA 23298-0540 - USA very high-affinity agents. e-mail: [email protected] INTRODUCTION were identified: σ1 and σ2 (reviewed: Bowen, 2000). These two receptor populations differed in their tissue The possible existence of putative sigma (σ) opioid distribution and subcellular localization. The benzomorphan receptors was proposed by William Martin in the mid 1970s (+)pentazocine displays several hundred-fold selectivity for to account for the binding of benzomorphans such as N- the former whereas DTG binds nearly equally well at both allylnormetazocine (NANM; SKF 10,047; 1) and populations.
    [Show full text]